An Indian-origin pharmacist and his employee have each been sentenced to six years in prison by a UK court for defrauding the National Health Service of more than 15 crore rupees. Jignesh Patel, 46, who owned Wise Pharmacy in north London, and Rahil Patel, 42, an employee at his pharmaceutical wholesale firm Actipharm Limited, were convicted at Southwark Crown Court following a three-week trial. Jurors found both men guilty of three counts of fraud by false representation and two counts of converting criminal property after evidence showed they used forged prescriptions to claim reimbursement from the public health system and illicitly sold the drugs to European wholesalers.
Dispensing of Hospital Drugs Unravels Large-Scale Operation
The cross-border operation began to unravel when the NHS Counter Fraud Authority identified unusual dispensing patterns at Wise Pharmacy. Investigators noted that the community chemist was routinely supplying high-cost medications that are normally restricted to hospital settings rather than primary care. Checks conducted with local healthcare commissioning groups revealed that the general practitioners whose names appeared on the paperwork had never authorized the prescriptions, and patient records confirmed no medical requirement for the items.
Authorities examined all prescription records handled by the pharmacy between January 2015 and November 2017, identifying seven costly medications at the centre of the scheme: Sprycel, Noxafil, Atripla, Eviplera, Tobramycin, Truvada, and Viread. In total, the probe uncovered 1,639 fraudulent prescriptions using the names of 24 doctors and covering 440 patients, amounting to 6,983 dispensed items. The NHS paid out more than 15 crore rupees in fraudulent reimbursements to Wise Pharmacy, while the medicines themselves were diverted and sold overseas through Actipharm.
International Inquiries Trace Diverted Stocks to European Wholesalers
Building the case required coordination across several jurisdictions, prompting the UK Crown Prosecution Service to submit European Investigation Orders to prosecutors in the Netherlands, Germany, and Belgium in November 2018. Investigators subsequently presented their evidence to German counterparts at Eurojust in The Hague in May 2019. By March 2020, Danish police, working alongside UK officers, inspected a wholesaler in Copenhagen, establishing a direct paper trail between the supplies obtained by Wise Pharmacy and their export to European buyers.
Police arrested Jignesh Patel on December 6, 2017, seizing approximately 22 lakh rupees in cash during a search of his premises. Rahil Patel was interviewed under caution in February 2020. During the court proceedings, prosecutors produced incriminating text messages exchanged between the two men, which showed active discussions regarding the procurement of fake prescriptions and the sourcing of medicines.
Regulatory Breaches Solidify Convictions as NHS Targets Asset Recovery
Regulatory requirements enforced by the Medicines and Healthcare products Regulatory Agency proved pivotal to the prosecution. Rules mandate that licensed wholesale distributors designate a Responsible Person to ensure strict compliance and maintain detailed transaction logs. Both Jignesh and Rahil Patel served as Responsible Persons for Actipharm during the indictment period. Inquiries revealed that Actipharm sold substantial volumes of pharmaceuticals to external distributors while maintaining no valid purchase records, linking the stock directly to the fraudulent NHS dispensations.
Sentencing the pair, Justice Cole described the enterprise as a serious offence motivated by greed, noting that the two men acted as equal partners in the lucrative scheme. With both defendants now imprisoned, the NHS Counter Fraud Authority has confirmed it will initiate confiscation proceedings under the Proceeds of Crime Act 2002 to claw back the stolen public funds.
Follow for daily updates on cybercrime, corporate fraud, DFIR, hacking, investigations, and digital forensics
